
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Cochrane database of systematic reviews
- Publicado em
- 18 mai 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Samantha Pillay, Karen R Steingart, Geraint R Davies, Marty Chaplin, Margaretha De Vos, Samuel G Schumacher, Rob Warren, Grant Theron
Descritores MeSH
- Tuberculosis, Lymph Node
- Tuberculosis, Pulmonary
- Tuberculosis, Multidrug-Resistant
- Antibiotics, Antitubercular
- Mycobacterium tuberculosis
- Microbial Sensitivity Tests
- Rifampin
- Sensitivity and Specificity
- Fluoroquinolones
- Adult
Veja também
Estudos relacionados
- Integrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis
- Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
- Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
- Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children